safety data

Takeda HQ

Biotech

Takeda stops narcolepsy clinical trials because of safety signal

Takeda has hit the brakes hard on its narcolepsy program in response to a safety signal, stopping its two midphase clinical trials early.

Nick Paul Taylor Oct 6, 2021 4:45am

heart model

FDA takes note of stroke-preventing heart implant risk in women

Sep 29, 2021 11:56am

blood test

Aprea's myeloid program iced by FDA on adverse events

Aug 6, 2021 10:30am

head and brain

Lumosa's stroke drug lowers risk of deadly complication

Aug 4, 2021 10:35am

Pascal Soriot

FDA expands probe into safety of AstraZeneca's COVID-19 vaccine

Oct 1, 2020 7:30am

Pascal Soriot

AstraZeneca's COVID-19 vaccine pause has NIH 'very concerned'

Sep 16, 2020 7:40am